US Patent Issued to Celgene Quanticel Research on Oct. 21 for "Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome" (California, New York, Missouri, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,171, issued on Oct. 21, was assigned to Celgene Quanticel Research Inc. (San Diego).

"Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome" was invented by C L Beach (Lee's Summit, Mo.), Shelonitda Rose (Branchburg, N.J.), Diana R. Dunshee (Alamo, Calif.), Daniel E. Lopes De Menezes (Berkeley, Calif.), Kyle MacBeth (Santa Rosa, Calif.), Yumin Dai (Danville, Calif.), Jessica Jang (New York) and Mark Frattini (Ridgewood, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for using 5-azacytidine in combination with additional agents to tre...